New York 2025-2026 Regular Session

New York Senate Bill S03393

Introduced
1/27/25  
Refer
1/27/25  
Engrossed
2/26/25  
Refer
2/26/25  
Refer
6/5/25  
Engrossed
6/12/25  
Refer
6/12/25  

Caption

Requires pharmacies that are permanently discontinuing to notify customers of such discontinuance and provide information including locations of other nearby pharmacies.

Impact

The bill seeks to enhance consumer protection in the pharmaceutical sector by fostering a communication framework that can help prevent disruptions in medication access. By requiring pharmacies to post discontinuation notices and notify patients directly, the bill underscores the importance of continuity in healthcare. It also aids in ensuring that patients have the necessary information to transition their prescriptions to nearby pharmacies without facing a lapse in their medication regimen.

Summary

Bill S03393, known as the Pharmacy Notification Bill, mandates that pharmacies inform customers of their permanent discontinuance at least thirty days in advance. The notification must be provided to customers who have had a prescription filled in the past year through their primary communication means and must also be prominently posted in the pharmacy. This initiative aims to ensure that patients are aware of such changes, reducing potential gaps in their healthcare access due to pharmacy closures.

Contention

While the bill is viewed positively by supporters who advocate for improved patient communication, there may be concerns regarding the burden it places on pharmacies, especially smaller, independently-owned establishments. Critics may contend that this requirement could potentially lead to increased operational costs or challenges in adhering to compliance, particularly for businesses with limited staffing resources. Balancing the mandate for notification with the operational capabilities of pharmacies remains a key discussion point.

Voting_history

The bill was passed with significant support in the Senate, having received 60 votes in favor and only 1 against during its final passage on February 26, 2025. This indicates broad legislative backing, highlighting the recognition of the bill's importance in maintaining pharmacy practice standards and protecting patient interests.

Companion Bills

NY A02278

Same As Requires pharmacies that are permanently discontinuing to notify customers of such discontinuance and provide information including locations of other nearby pharmacies.

Previously Filed As

NY A09769

Requires pharmacies that are discontinuing to notify customers of such discontinuance and provide information including locations of other nearby pharmacies.

NY S09525

Requires pharmacies that are discontinuing to notify customers of such discontinuance and provide information including locations of other nearby pharmacies.

NY S06384

Establishes duties for pharmacies when pharmacists employed by such pharmacy refuse to fill prescriptions on the basis of personal beliefs; requires a pharmacy to ensure the prescription is filled by another pharmacist; requires the pharmacy to inform individuals of items not in stock; requires such items to be ordered by another pharmacist without delay; sets forth penalty provisions.

NY A09487

Establishes duties for pharmacies when pharmacists employed by such pharmacy refuse to fill prescriptions on the basis of personal beliefs; requires a pharmacy to ensure the prescription is filled by another pharmacist; requires the pharmacy to inform individuals of items not in stock; requires such items to be ordered by another pharmacist without delay; sets forth penalty provisions.

NY A09729

Establishes conditions under which resident or non-resident pharmacists and pharmacies may participate in shared pharmacy services.

NY S09186

Establishes conditions under which resident or non-resident pharmacists and pharmacies may participate in shared pharmacy services.

NY S01681

Requires certain pharmacies to establish, pay for, and operate a drug take back system at no cost to customers.

NY A10668

Requires that pharmacists get express written consent before substituting a drug product for a less expensive drug product, including biological products.

NY A09764

Prohibits pharmacy benefit managers from penalizing pharmacies for providing customers certain information relating to the costs of prescription medications and services.

NY S09040

Prohibits pharmacy benefit managers from penalizing pharmacies for providing customers certain information relating to the costs of prescription medications and services.

Similar Bills

No similar bills found.